Georgina Davis

954 total citations
18 papers, 400 citations indexed

About

Georgina Davis is a scholar working on Infectious Diseases, Epidemiology and Molecular Biology. According to data from OpenAlex, Georgina Davis has authored 18 papers receiving a total of 400 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Infectious Diseases, 10 papers in Epidemiology and 5 papers in Molecular Biology. Recurrent topics in Georgina Davis's work include Clostridium difficile and Clostridium perfringens research (16 papers), Microscopic Colitis (10 papers) and Viral gastroenteritis research and epidemiology (5 papers). Georgina Davis is often cited by papers focused on Clostridium difficile and Clostridium perfringens research (16 papers), Microscopic Colitis (10 papers) and Viral gastroenteritis research and epidemiology (5 papers). Georgina Davis collaborates with scholars based in United Kingdom, Switzerland and Slovenia. Georgina Davis's co-authors include Mark H. Wilcox, Kerrie Davies, Christopher Longshaw, D.A. BURNS, Helen Ashwin, Sharanne Raidal, Barbara Padalino, Anthony M. Buckley, Inês B. Moura and Emma Clark and has published in prestigious journals such as Journal of Biological Chemistry, Annals of Oncology and Journal of Antimicrobial Chemotherapy.

In The Last Decade

Georgina Davis

18 papers receiving 397 citations

Peers

Georgina Davis

EPIDE

CCICM

SURGE

Niki F. Foster Australia

E. C. Keessen Netherlands

Richard Kirton United Kingdom

Michele M. Squire Australia

Fabian K. Berger Germany

Emma Clark United Kingdom

Carlos Quesada-Gómez Costa Rica

Jessica L. Schlackman United States

Katie Solomon Ireland

S. L. Todhunter United Kingdom

Niki F. Foster Australia

Georgina Davis

421 ×1.3

258 ×1.4

EPIDE

113 ×1.2

69 ×0.9

CCICM

62 ×1.0

SURGE

Citations per year, relative to Georgina Davis Georgina Davis (= 1×) peers Niki F. Foster

Countries citing papers authored by Georgina Davis

Since Specialization

Citations

This map shows the geographic impact of Georgina Davis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Georgina Davis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Georgina Davis more than expected).

Fields of papers citing papers by Georgina Davis

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Georgina Davis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Georgina Davis. The network helps show where Georgina Davis may publish in the future.

Co-authorship network of co-authors of Georgina Davis

This figure shows the co-authorship network connecting the top 25 collaborators of Georgina Davis. A scholar is included among the top collaborators of Georgina Davis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Georgina Davis. Georgina Davis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Rosenberg, Jacob, Daniel P. Petrylak, Thomas W. Flaig, et al.. (2024). 1968P Study EV-103 dose escalation/cohort A (DE/A): 5y follow-up of first-line (1L) enfortumab vedotin (EV) + pembrolizumab (P) in cisplatin (CIS)-ineligible locally advanced or metastatic urothelial carcinoma (la/mUC). Annals of Oncology. 35. S1139–S1140. 2 indexed citations

Rupnik, Maja, Virginie Viprey, Sandra Janežič, et al.. (2024). Distribution of Clostridioides difficile ribotypes and sequence types across humans, animals and food in 13 European countries. Emerging Microbes & Infections. 13(1). 2427804–2427804. 9 indexed citations

Freeman, Jane, Virginie Viprey, Emma Clark, et al.. (2024). Antimicrobial susceptibility in Clostridioides difficile varies according to European region and isolate source. JAC-Antimicrobial Resistance. 6(4). dlae112–dlae112. 1 indexed citations

Greetham, Darren, Michael P. Williamson, Caroline A. Evans, et al.. (2023). Clostridioides difficile canonical L,D-transpeptidases catalyze a novel type of peptidoglycan cross-links and are not required for beta-lactam resistance. Journal of Biological Chemistry. 300(1). 105529–105529. 6 indexed citations

Agnew, Emily, Kerrie Davies, Virginie Viprey, et al.. (2023). Impact of testing on Clostridioides difficile infection in hospitals across Europe: a mathematical model. Clinical Microbiology and Infection. 29(6). 796.e1–796.e6. 5 indexed citations

Viprey, Virginie, Georgina Davis, Sandra Janežič, et al.. (2022). Clostridioides difficile positivity rate and PCR ribotype distribution on retail potatoes in 12 European countries, January to June 2018. Eurosurveillance. 27(15). 16 indexed citations

Viprey, Virginie, Georgina Davis, Jon J. Vernon, et al.. (2022). A point-prevalence study on community and inpatient Clostridioides difficile infections (CDI): results from Combatting Bacterial Resistance in Europe CDI (COMBACTE-CDI), July to November 2018. Eurosurveillance. 27(26). 29 indexed citations

Moura, Inês B., Jessica A. Bryant, Emma Clark, et al.. (2021). Biofilms harbour Clostridioides difficile, serving as a reservoir for recurrent infection. npj Biofilms and Microbiomes. 7(1). 16–16. 47 indexed citations

Buckley, Anthony M., Inês B. Moura, Norie Arai, et al.. (2021). Trehalose-Induced Remodelling of the Human Microbiota Affects Clostridioides difficile Infection Outcome in an In Vitro Colonic Model: A Pilot Study. Frontiers in Cellular and Infection Microbiology. 11. 670935–670935. 21 indexed citations

10.

Viprey, Virginie, Georgina Davis, Jon J. Vernon, et al.. (2021). Key Differences in Diagnosis and Patient Populations between Community and In-Patient <i>Clostridioides Difficile Infections</i> (CDI): Results from Combatting Bacterial Resistance in Europe CDI (COMBACTE-CDI). SSRN Electronic Journal. 1 indexed citations

11.

Buckley, Anthony M., Inês B. Moura, Emma Clark, et al.. (2021). The use of first-generation cephalosporin antibiotics, cefalexin and cefradine, is not associated with induction of simulated Clostridioides difficile infection. Journal of Antimicrobial Chemotherapy. 77(1). 148–154. 9 indexed citations

12.

Davies, Kerrie, Georgina Davis, Frédéric Barbut, et al.. (2020). Factors affecting reported Clostridioides difficile infection rates; the more you look the more you find, but should you believe what you see?. Anaerobe. 62. 102178–102178. 9 indexed citations

13.

Padalino, Barbara, Georgina Davis, & Sharanne Raidal. (2020). Effects of transportation on gastric pH and gastric ulceration in mares. Journal of Veterinary Internal Medicine. 34(2). 922–932. 27 indexed citations

14.

Davies, Kerrie, Jody Lawrence, Georgina Davis, et al.. (2020). Risk Factors for Primary Clostridium difficile Infection; Results From the Observational Study of Risk Factors for Clostridium difficile Infection in Hospitalized Patients With Infective Diarrhea (ORCHID). Frontiers in Public Health. 8. 293–293. 46 indexed citations

15.

Davies, Kerrie, Virginie Viprey, Jon J. Vernon, et al.. (2020). Burden of Clostridium difficile Infection (CDI) Across Whole Healthcare Economies and European Borders; COMBACTE-CDI Results. Infection Control and Hospital Epidemiology. 41(S1). s24–s25. 1 indexed citations

16.

Buckley, Anthony M., et al.. (2020). Eravacycline, a novel tetracycline derivative, does not induceClostridioides difficileinfection in anin vitrohuman gut model. Journal of Antimicrobial Chemotherapy. 76(1). 171–178. 10 indexed citations

17.

Davies, Kerrie, Helen Ashwin, Christopher Longshaw, et al.. (2016). Diversity of Clostridium difficile PCR ribotypes in Europe: results from the European, multicentre, prospective, biannual, point-prevalence study of Clostridium difficile infection in hospitalised patients with diarrhoea (EUCLID), 2012 and 2013. Eurosurveillance. 21(29). 144 indexed citations

18.

Davies, Kerrie, Georgina Davis, Frédéric Barbut, et al.. (2016). Variability in testing policies and impact on reported Clostridium difficile infection rates: results from the pilot Longitudinal European Clostridium difficile Infection Diagnosis surveillance study (LuCID). European Journal of Clinical Microbiology & Infectious Diseases. 35(12). 1949–1956. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact